First-line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial.

IF 3.8 2区医学 Q1 HEMATOLOGY

British Journal of Haematology Pub Date : 2025-10-12 DOI:10.1111/bjh.70209

Anthony S Stein, Andrew A Lane, Kendra L Sweet, Sumithira Vasu, Alessandra Tosolini, John Katsetos, Marina Konopleva, Naveen Pemmaraju

引用次数: 0

查看原文本刊更多论文

一线tagraxofusp在50岁以下的成年母浆细胞样树突状细胞肿瘤患者中诱导持久的反应并延长生存期：一项2期试验的事后分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British Journal of Haematology 医学-血液学

CiteScore

8.60

自引率

4.60%

发文量

565

审稿时长

1 months

期刊介绍： The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.